Virus-fating startup Single An investment round has closed a 10 million series and now selling his pathogen-beaten face masks AmazonThe
The Seattle Organization was also Elected To join the entrepreneurial initiative that embedded by the US Defense Advanced Research Projects Agency (DRPA). The program provides startups with DARPA assistance to promote technologies that can help us national protection.
Singalto is called Oxafance Active Protection, a technology that uses methylene blue, it uses a chemical known for killing viruses, bacteria and fungus. It is relatively safe for humans because methylene blue is used in the treatment of various health conditions.
Oxafance tests have shown that 99.9% of the specific viral strains were disabled within five minutes of contact with the mouth mask treated with the product. Technology is likely to be used in broad healthcare items.
Singalto received the FDA approval for Oxafance last year.
As part of the program of the Embed Entrepreneur Entrepreneur Initiative, infectious pathologist Kelly Bliz-Wise will be closely partner with Singelto to consider these other uses.
“Working with Singleto about the company’s first commercial product forward is exciting about the company’s first commercial product, which is currently the only FDA-celier mask in the United States that inactivates the tested viruses,”. StatementThe
“We are actively exploring applications in Warfighter protection, wound care and other fields where this platform can pay the real price,” he added.
As the flu and covid infections increase in winter, the introduction of a single mask on Amazon comes at a lucky time.
The CEO said “Leaving Amazon is an important step for us” John BajouronThe “Our purpose is to reach nurses who do not have access to these options through their employers, as well as other people and families who have extra anxiety and they are looking for something that gives them better confidence.”
A box of 50, the American -made oxaffens mask is currently provided for $ 38 on Amazon. The prices for competitive products are widely changed to the same amount of the N95 mask made from the US to the US, while the similar masks from China are available at less than $ 20.
Singleto was launched in 2021 and its co-founders have deep roots of healthcare and entrepreneurs in the North West. Dr. Tom LendbeChief Medical Officer, Seattle Children’s Hospital and a pediatric urologist at the University of Washington. Dr. Jim ChenChief Science Officer, a former neurosurgeon who had previously launched an oncology research agency.
Related: FDA is approved for startup viruses led by Seattle Physicians, for surgical mask technology